Risk of renal damage associated with intravitreal anti-VEGF therapy for diabetic macular edema in routine clinical practice

PURPOSE: Vascular endothelial growth factor inhibitors (anti-VEGF) have been shown to be effective in the treatment of diabetic macular edema. However, there is little information about the systemic effects of intraocular administration of anti-VEGF drugs in patients with coexistent diabetic nephrop...

Descripción completa

Detalles Bibliográficos
Autores principales: del Cura, Mar Prieto, Carballés, María J C, Sastre-Ibáñez, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538817/
https://www.ncbi.nlm.nih.gov/pubmed/37530286
http://dx.doi.org/10.4103/IJO.IJO_44_23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538817/
https://www.ncbi.nlm.nih.gov/pubmed/37530286
http://dx.doi.org/10.4103/IJO.IJO_44_23

Ejemplares similares